• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease
 
  • Details
  • Full
Options
2025
Journal Article
Title

RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease

Abstract
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide, leading to cognitive and functional decline. Early detection and intervention are crucial for enhancing the quality of life of patients and their families. Remote Monitoring Technologies (RMTs) offer a promising solution for early detection by tracking changes in behavioral and cognitive functions, such as memory, language, and problem-solving skills. Timely detection of these symptoms can facilitate early intervention, potentially slowing disease progression and enabling appropriate treatment and care. Methods: The RADAR-AD study was designed to evaluate the accuracy and validity of multiple RMTs in detecting functional decline across various stages of AD in a real-world setting, compared to standard clinical rating scales. Our approach involved a univariate analysis using Analysis of Covariance (ANCOVA) to analyze individual features of six RMTs while adjusting for variables such as age, sex, years of education, clinical site, BMI and season. Additionally, we employed four machine learning classifiers – Logistic Regression, Decision Tree, Random Forest, and XGBoost – using a nested cross-validation approach to assess the discriminatory capabilities of the RMTs. Results: The ANCOVA results indicated significant differences between healthy and AD subjects regarding reduced physical activity, less REM sleep, altered gait patterns, and decreased cognitive functioning. The machine-learning-based analysis demonstrated that RMT-based models could identify subjects in the prodromal stage with an Area Under the ROC Curve of 73.0 %. In addition, our findings show that the Amsterdam iADL questionnaire has high discriminatory abilities. Conclusions: RMTs show promise in AD detection already in the prodromal stage. Using them could allow for earlier detection and intervention, thereby improving patients’ quality of life. Furthermore, the Amsterdam iADL questionnaire holds high potential when employed remotely.
Author(s)
Lentzen, Manuel
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Vairavan, Srinivasan
Janssen Research & Development
Muurling, Marijn
Vrije Universiteit Amsterdam
Alepopoulos, Vasilis
Centre for Research and Technology-Hellas
Atreya, Alankar
University of Oxford
Boada, Mercé
Universitat Internacional de Catalunya
de Boer, Casper
Vrije Universiteit Amsterdam
Conde, Pauline
King's College London
Curcic, Jelena
Novartis International AG
Frisoni, Giovanni B.
Hôpitaux Universitaires de Genève
Galluzzi, Samantha
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Gjestsen, Martha Therese
Stavanger Universitetssjukehus
Gkioka, Mara
Aristotle University of Thessaloniki
Grammatikopoulou, Margarita
Centre for Research and Technology-Hellas
Hausner, Lucrezia
Medizinische Fakultät Mannheim
Hinds, Chris
University of Oxford
Lazarou, Ioulietta
Centre for Research and Technology-Hellas
de Mendonça, Alexandre V.
Faculdade de Medicina da Universidade de Lisboa
Nikolopoulos, Spiros N.
Centre for Research and Technology-Hellas
Religa, Dorota D.
Karolinska Institutet
Scebba, Gaetano C.
Novartis International AG
Jelle Visser, Pieter
Vrije Universiteit Amsterdam
Wittenberg, Gayle M.
Janssen Research & Development
Narayan, Vaibhav A.
Davos Alzheimer's Collaborative
Coello, Neva
Novartis International AG
Brem, Anna Katharine
King's College London
Aarsland, Dag
King's College London
Fröhlich, Holger  
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Journal
Alzheimer's research & therapy  
Open Access
DOI
10.1186/s13195-025-01675-0
Additional full text version
Landing Page
Language
English
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI  
Keyword(s)
  • Alzheimer’s disease

  • Discriminative capacity

  • Mobile applications

  • Remote monitoring technologies

  • Wearables

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024